Conference abstractPublished 18 Dec 2018
Effects of policosanol in the functional recovery of ischemic stroke hypertensive patients
National Centre for Scientific Research, CubaInstitute of Neurology and Neurosurgery, CubaSurgical Medical Research Centre, Cuba
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: Stroke is one of the leading causes of mortality and disability. Clinical studies results show that policosanol (20 mg/day) + standard aspirin (AS) therapy had benefits versus placebo + AS given for 6 and 12 months to patients with recent ischemic stroke. Objective: To analysis, the policosanol treatment effects in the hypertensive patients included in two ischemic stroke recovery trials. Methods: This report was analyzed the records of all hypertensive patients included in two ischemic stroke recovery studies. Hypertensive patients with a modified Rankin Scale score (mRSs) 2 to 4 were randomized, within 30 days of onset, to policosanol/ AS or placebo/AS, for 6 months. The primary outcome was a mRSs reduction. Low-density Lipoprotein-cholesterol (LDL-C) reduction and High-Density Lipoprotein-Cholesterol (HDL-C) increase were secondary outcomes. Results: One hundred forty-two hypertensive patients (mean age: 66 years) were included in the analysis. Policosanol/AS decreased significantly the mRSs mean from the first interim check-up (3 months) (p<0.0001 vs. placebo/AS). The policosanol treatment effect did not wear off, on the contrary, even improved after 6 months therapy (p<0.0001 versus placebo/AS). Moreover, policosanol/AS (57/71; 80.3%) treatment achieved significant results (mRSs ≤1; p<0.0001). Whereas the placebo/ AS did not (6/71; 8.5%). Treatments were well tolerated. Two patients discontinued prematurely and four patients (2 from policosanol/AS group and 2 from placebo/AS) referred mild AE. Conclusions: Six months administration of policosanol/AS given to hypertensive patients after suffering ischemic stroke demonstrated to be better than placebo/AS in improving functional outcomes at 3 and 6 months when used among hypertensive patients with ischemic stroke.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Analytical & Bioanalytical Techniques
- SubjectBiochemistry & Biotechnology
- SubjectChemistry
- BylineArticles whose byline prints “Julio C Fernandez Javier Sanchez”
- BylineArticles whose byline prints “Jose Illnait”
- BylineArticles whose byline prints “Lilia Fernandez”
- BylineArticles whose byline prints “Sarahi Mendoza”
- BylineArticles whose byline prints “Rosa Mas”
- BylineArticles whose byline prints “Pablo Reyes”
- BylineArticles whose byline prints “Meilis Mesa”